Management of Covid-19 Patients During Home Isolation

Covid 19 Clinical Trial

Official title:

Management of Covid-19 Patients During Home Isolation

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04368923
• Other study ID #: REC/012-2020
• Status: Active, not recruiting
• Phase: N/A
• Start date: March 15, 2020
• Est. completion date: June 23, 2020

Study information

• Verified date: June 2020
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will be concerned with managing patients of Covid-19 while being home isolated.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 60
• Est. completion date: June 23, 2020
• Est. primary completion date: June 21, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years to 40 Years

Eligibility

Inclusion Criteria:

• Patients with Covid-19

• American Society of Anesthesiologists (ASA) class I

• >= 21 years old

• <= 40 years old

Exclusion Criteria:

• ASA class II, class III or class IV

Related Conditions & MeSH terms

• Covid 19

Intervention

Device:
• Oxygen Therapy
Patients receive oxygen therapy

Procedure:
• Physical Therapy
Patients receive physical therapy

Locations

Country	Name	City	State
Egypt	M. Sedky	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Arterial Blood Gases (ABG): Partial Pressure of Oxygen and Carbon Dioxide		48 hours
Primary	Arterial Blood Gases (ABG): Acidity Potential Hydrogen (pH)		48 hours
Secondary	Vital Signs (Temprature)		24 hours
Secondary	Vital Signs (Respiratory Rate)		24 hours
Secondary	Vital Signs (Oxygen Saturation)		24 hours
Secondary	Vital Signs (Heart Rate)		24 hours
Secondary	Vital Signs (Blood Pressure)		24 hours